[1]
“CLINICAL EFFECTIVENESS OF IMPROVING DIAGNOSTIC AND THERAPEUTIC APPROACHES FOR ASSESSING THE METABOLIC ACTIVITY OF THE GUT MICROBIOTA IN PATIENTS WITH ISCHEMIC HEART DISEASE: UDC: 616.12-005.4:612.39:579.835”, ICSMSI, vol. 2, no. 3, pp. 18–23, Mar. 2026, Accessed: Apr. 04, 2026. [Online]. Available: https://eoconf.com/index.php/icsmsi/article/view/913